These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12190306)

  • 1. Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.
    Murugesan N; Tellew JE; Gu Z; Kunst BL; Fadnis L; Cornelius LA; Baska RA; Yang Y; Beyer SM; Monshizadegan H; Dickinson KE; Panchal B; Valentine MT; Chong S; Morrison RA; Carlson KE; Powell JR; Moreland S; Barrish JC; Kowala MC; Macor JE
    J Med Chem; 2002 Aug; 45(18):3829-35. PubMed ID: 12190306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics.
    Murugesan N; Gu Z; Fadnis L; Tellew JE; Baska RA; Yang Y; Beyer SM; Monshizadegan H; Dickinson KE; Valentine MT; Humphreys WG; Lan SJ; Ewing WR; Carlson KE; Kowala MC; Zahler R; Macor JE
    J Med Chem; 2005 Jan; 48(1):171-9. PubMed ID: 15634011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist.
    Murugesan N; Gu Z; Spergel S; Young M; Chen P; Mathur A; Leith L; Hermsmeier M; Liu EC; Zhang R; Bird E; Waldron T; Marino A; Koplowitz B; Humphreys WG; Chong S; Morrison RA; Webb ML; Moreland S; Trippodo N; Barrish JC
    J Med Chem; 2003 Jan; 46(1):125-37. PubMed ID: 12502366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308).
    Murugesan N; Gu Z; Stein PD; Bisaha S; Spergel S; Girotra R; Lee VG; Lloyd J; Misra RN; Schmidt J; Mathur A; Stratton L; Kelly YF; Bird E; Waldron T; Liu EC; Zhang R; Lee H; Serafino R; Abboa-Offei B; Mathers P; Giancarli M; Seymour AA; Webb ML; Hunt JT
    J Med Chem; 1998 Dec; 41(26):5198-218. PubMed ID: 9857090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.
    Tellew JE; Baska RA; Beyer SM; Carlson KE; Cornelius LA; Fadnis L; Gu Z; Kunst BL; Kowala MC; Monshizadegan H; Murugesan N; Ryan CS; Valentine MT; Yang Y; Macor JE
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1093-6. PubMed ID: 12643919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonists.
    Murugesan N; Gu Z; Stein PD; Spergel S; Mathur A; Leith L; Liu EC; Zhang R; Bird E; Waldron T; Marino A; Morrison RA; Webb ML; Moreland S; Barrish JC
    J Med Chem; 2000 Aug; 43(16):3111-7. PubMed ID: 10956219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.
    Bai R; Wei Z; Liu J; Xie W; Yao H; Wu X; Jiang J; Wang Q; Xu J
    Bioorg Med Chem; 2012 Aug; 20(15):4661-7. PubMed ID: 22750010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and structure-activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ET(B) receptor.
    Chan MF; Kois A; Verner EJ; Raju BG; Castillo RS; Wu C; Okun I; Stavros FD; Balaji VN
    Bioorg Med Chem; 1998 Dec; 6(12):2301-16. PubMed ID: 9925292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphenylsulfonamide endothelin receptor antagonists. Part 3: structure-activity relationship of 4'-heterocyclic biphenylsulfonamides.
    Murugesan N; Gu Z; Stein PD; Spergel S; Bisaha S; Liu EC; Zhang R; Webb ML; Moreland S; Barrish JC
    Bioorg Med Chem Lett; 2002 Feb; 12(4):517-20. PubMed ID: 11844662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dual action AT1 and ETA receptor antagonists reduce blood pressure in experimental hypertension.
    Kowala MC; Murugesan N; Tellew J; Carlson K; Monshizadegan H; Ryan C; Gu Z; Kane B; Fadnis L; Baska RA; Beyer S; Arthur S; Dickinson K; Zhang D; Perrone M; Ferrer P; Giancarli M; Baumann J; Bird E; Panchal B; Yang Y; Trippodo N; Barrish J; Macor JE
    J Pharmacol Exp Ther; 2004 Apr; 309(1):275-84. PubMed ID: 14718594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonists.
    Bolli MH; Boss C; Clozel M; Fischli W; Hess P; Weller T
    Bioorg Med Chem Lett; 2003 Mar; 13(5):955-9. PubMed ID: 12617929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and structure-activity relationships of sulfonamide ETA-selective antagonists.
    Stein PD; Floyd DM; Bisaha S; Dickey J; Girotra RN; Gougoutas JZ; Kozlowski M; Lee VG; Liu EC; Malley MF
    J Med Chem; 1995 Apr; 38(8):1344-54. PubMed ID: 7731020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.
    Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Kivlighn SD; Siegl PK; Lotti VJ; Chang RS
    J Med Chem; 1995 Sep; 38(19):3741-58. PubMed ID: 7562905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin AT(1) receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling.
    Hines J; Fluharty SJ; Sakai RR
    Eur J Pharmacol; 1999 Nov; 384(1):81-9. PubMed ID: 10611423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives.
    Morimoto H; Shimadzu H; Kushiyama E; Kawanishi H; Hosaka T; Kawase Y; Yasuda K; Kikkawa K; Yamauchi-Kohno R; Yamada K
    J Med Chem; 2001 Oct; 44(21):3355-68. PubMed ID: 11585441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and synthesis of a potent sulfonamide ET(B) selective antagonist.
    Kanda Y; Takahashi T; Araki Y; Konoike T; Mihara S; Fujimoto M
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1875-8. PubMed ID: 10969989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New non-peptide endothelin-A receptor antagonists: synthesis, biological properties, and structure-activity relationships of 5-(dimethylamino)-N-pyridyl-,-N-pyrimidinyl-,-N-pyridazinyl-, and -N-pyrazinyl-1-naphthalenesulfonamides.
    Bradbury RH; Bath C; Butlin RJ; Dennis M; Heys C; Hunt SJ; James R; Mortlock AA; Sumner NF; Tang EK; Telford B; Whiting E; Wilson C
    J Med Chem; 1997 Mar; 40(6):996-1004. PubMed ID: 9083490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
    J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
    Vanderheyden PM; Fierens FL; De Backer J; Vauquelin G
    Biochem Pharmacol; 2000 Apr; 59(8):927-35. PubMed ID: 10692557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.